SurpassMD vs TrimRx: Entry Price vs Flat-Rate GLP-1 Pricing
Advertising disclosure: SurpassMD is an advertising partner of Peptide Dossier. Pricing and program facts below were verified in July 2026 and apply to both platforms equally.
SurpassMD and TrimRx represent the two competing pricing philosophies in compounded GLP-1 telehealth: the lowest advertised entry price ($134/month semaglutide at SurpassMD) versus one flat rate at every dose level ($349/month tirzepatide at TrimRx). Which saves you money depends almost entirely on where your dose ends up.
Side-by-Side Comparison (July 2026)
| Feature | SurpassMD | TrimRx |
|---|---|---|
| Semaglutide entry | From $134/mo | $179 first mo, then $299 |
| Semaglutide 12-mo prepay | No prepay required | $174/mo ($2,088 upfront) |
| Tirzepatide entry | From $199/mo | $279 first mo, then $399 |
| Tirzepatide flat plan | Price varies by dose | $349/mo at every dose |
| Dose escalation policy | Starting price; dose may raise cost | Flat — no increase with dose |
| Oral option | Oral semaglutide | None |
| Shipping | Cold, within 48 hours | 3-5 business days |
| Billing flexibility | Monthly, cancel anytime | Monthly or 3/6/12-mo prepay |
| Insurance | Cash-pay only | Cash-pay only |
| Coverage | 50 states + DC | Most states |
The Dose Trajectory Decides This Matchup
A patient who starts semaglutide and stays at a low maintenance dose pays SurpassMD's low entry pricing indefinitely and never benefits from flat-rate insurance. A patient titrating tirzepatide to 12.5-15mg is exactly who TrimRx's $349 flat rate protects — at dose-tiered platforms that course can run $400+ by month six. Neither model is universally cheaper; your titration plan picks the winner. Our tirzepatide dosage chart and semaglutide dosing chart show typical escalation schedules.
One more asymmetry: TrimRx's intro price expires — $179 becomes $299 in month two on rolling plans. SurpassMD's $134 is an entry dose price, not a promotional month. Confirm both at checkout for your specific dose.
Verdict: Which Should You Choose?
Start with SurpassMD if you are new to GLP-1s: lower entry cost, faster shipping, no prepay pressure, and an oral semaglutide option while you learn your tolerance. Move to (or start with) TrimRx if your provider expects a high maintenance dose and you want the whole course priced upfront. Committed 12-month semaglutide users should also price Fridays' $150/month prepay before deciding — see SurpassMD vs Fridays.
Full reviews: SurpassMD review and TrimRx review. The whole field is ranked in best GLP-1 telehealth providers.
Frequently Asked Questions
For month one, SurpassMD: $134/month advertised versus TrimRx's $179 intro. From month two on a rolling plan, TrimRx jumps to $299/month while SurpassMD's entry pricing starts lower, though both platforms' actual prices depend on the dose prescribed. On 12-month prepay, TrimRx reaches $174/month effective. The honest comparison requires knowing your maintenance dose: advertised floors decide month one, dose policy decides the year.
Entry pricing (SurpassMD's model) advertises the lowest starting-dose price, with cost varying as dose changes. Flat pricing (TrimRx's model) charges one rate at every dose level — $349/month tirzepatide from 2.5mg through maximum. Entry pricing wins for patients staying at low doses; flat pricing wins for patients titrating high, because dose-based increases never hit.
At entry, SurpassMD: $199/month advertised versus TrimRx's $279 intro month and $399 rolling ($349 on the flat plan, $283/month on 12-month prepay). At high maintenance doses the answer can flip if SurpassMD's dose-based pricing rises above TrimRx's flat $349. Ask SurpassMD what your target maintenance dose costs before assuming the entry price holds.
Neither requires it. SurpassMD advertises its entry pricing without a prepay commitment and is cancel-anytime. TrimRx offers month-to-month billing but reserves its best rates ($174/month semaglutide, $283/month tirzepatide) for 12-month prepaid plans costing $2,088-3,396 upfront. If you have not confirmed you tolerate GLP-1 medication, month-to-month at either platform beats prepaying.
Both use the standard asynchronous model: online intake, independent licensed provider review, pharmacy fulfillment. SurpassMD advertises cold shipping within 48 hours of approval; TrimRx quotes 3-5 business days. Both are cash-pay platforms that accept HSA/FSA, and both facilitate compounded medications that are not FDA-approved.
Choose SurpassMD for the lowest entry price ($134 semaglutide, $199 tirzepatide), 48-hour shipping, and no-prepay flexibility. Choose TrimRx if you are confident you will titrate to a high maintenance dose and want price certainty across the whole course, or if you will prepay 12 months for the $174/month rate. First-time GLP-1 users are usually better off starting month-to-month and switching once their dose stabilizes.
This page is informational and is not medical advice. SurpassMD is an advertising partner of Peptide Dossier. Compounded medications are not FDA-approved or reviewed for safety, effectiveness, or quality. Prescriptions are never guaranteed. Pricing verified July 2026 and subject to change.